USANA Health Sciences (NYSE:USNA) Upgraded by ValuEngine to “Buy”

ValuEngine upgraded shares of USANA Health Sciences (NYSE:USNA) from a hold rating to a buy rating in a research note issued to investors on Tuesday morning, ValuEngine reports.

Several other research analysts have also recently weighed in on the stock. Jefferies Financial Group assumed coverage on shares of USANA Health Sciences in a report on Thursday, August 22nd. They issued a hold rating and a $65.00 price target on the stock. Zacks Investment Research upgraded USANA Health Sciences from a hold rating to a strong-buy rating and set a $86.00 target price for the company in a research report on Saturday, October 26th. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of Buy and an average price target of $74.00.

Shares of NYSE:USNA traded up $1.88 during trading on Tuesday, hitting $76.35. 74,217 shares of the company were exchanged, compared to its average volume of 229,750. USANA Health Sciences has a 52-week low of $58.30 and a 52-week high of $125.61. The stock has a 50 day moving average of $73.43 and a 200 day moving average of $70.27. The company has a market cap of $1.59 billion, a PE ratio of 14.80 and a beta of 0.30.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $1.09 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.87 by $0.22. USANA Health Sciences had a return on equity of 27.60% and a net margin of 9.38%. The company had revenue of $260.60 million during the quarter, compared to analysts’ expectations of $256.22 million. During the same period in the previous year, the business earned $1.24 earnings per share. The firm’s quarterly revenue was down 12.2% compared to the same quarter last year. On average, analysts anticipate that USANA Health Sciences will post 3.99 earnings per share for the current fiscal year.

In other USANA Health Sciences news, CFO G Doug Iiekking sold 1,746 shares of USANA Health Sciences stock in a transaction that occurred on Friday, October 25th. The stock was sold at an average price of $75.33, for a total value of $131,526.18. Following the transaction, the chief financial officer now directly owns 2,032 shares of the company’s stock, valued at approximately $153,070.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Walter Noot sold 1,176 shares of the business’s stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $75.98, for a total value of $89,352.48. Following the completion of the sale, the chief operating officer now owns 1,444 shares of the company’s stock, valued at approximately $109,715.12. The disclosure for this sale can be found here. Insiders have sold 8,385 shares of company stock worth $617,279 over the last ninety days. Insiders own 42.50% of the company’s stock.

Several institutional investors have recently modified their holdings of USNA. Metropolitan Life Insurance Co NY increased its position in USANA Health Sciences by 20.0% during the 3rd quarter. Metropolitan Life Insurance Co NY now owns 4,876 shares of the company’s stock valued at $333,000 after purchasing an additional 814 shares during the period. Squarepoint Ops LLC lifted its position in shares of USANA Health Sciences by 37.4% in the 3rd quarter. Squarepoint Ops LLC now owns 37,247 shares of the company’s stock worth $2,547,000 after purchasing an additional 10,147 shares during the period. Voloridge Investment Management LLC bought a new stake in shares of USANA Health Sciences during the 3rd quarter valued at about $1,522,000. Barclays PLC boosted its stake in shares of USANA Health Sciences by 1.6% during the 3rd quarter. Barclays PLC now owns 24,660 shares of the company’s stock valued at $1,687,000 after purchasing an additional 398 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its stake in shares of USANA Health Sciences by 44.5% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 14,033 shares of the company’s stock valued at $960,000 after purchasing an additional 4,324 shares in the last quarter. Hedge funds and other institutional investors own 52.87% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.

Further Reading: Current Ratio

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.